Hamill John P.
- SEC CIK
- 0001716213
In the past year, 2 open-market purchase filings worth $10.9K and no sales.
Current role at each company
- APRE Aprea Therapeutics, Inc.SrVP/CFO/Prin Fin & Acct Ofcras of Apr 1, 2026
- WINT Windtree Therapeutics IncSVP & CFOas of Jul 26, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $10.9K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$10.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Hamill John P. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
APRE Aprea Therapeutics, Inc.
SrVP/CFO/Prin Fin & Acct Ofcr9 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 1, 2026 (view filing) | Mar 31 | 1 day | Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr | PPurchase | +62.0K | $0.81 | +$25.1K | –31.0K after | Derivative2 lots |
| Feb 2, 2026 (view filing) | Jan 30 | 3 days | Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr | PPurchase | +5.70K | $0.89 | +$5.07K | +20.6%33.4K after | |
| Feb 2, 2026 (view filing) | Jan 30 | 3 days | Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr | PPurchase | +5.70K | – | – | –5.70K after | Derivative |
| Dec 11, 2025 (view filing) | Dec 10 | 1 day | Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr | PPurchase | +5.00K | $1.17 | +$5.85K | +22.0%27.7K after | |
| Dec 11, 2025 (view filing) | Dec 10 | 1 day | Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr | PPurchase | +5.00K | – | – | –5.00K after | Derivative |
| Oct 16, 2024 (view filing) | Oct 11 | 5 days | Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr | PPurchase | +50 | $2.46 | +$123 | +0.3%19.4K after | |
| Oct 15, 2024 (view filing) | Oct 10 | 5 days | Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr | PPurchase | +450 | $2.61 | +$1.17K | +2.4%19.3K after | |
| Mar 14, 2024 (view filing) | Mar 13 | 1 day | Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr | PPurchase | +1.01K | $7.29 | +$7.36K | +7.0%15.5K after | |
| Mar 14, 2024 (view filing) | Mar 13 | 1 day | Hamill John P.SrVP/CFO/Prin Fin & Acct Ofcr | PPurchase | +1.01K | – | – | –505 after | Derivative2 lots |
WINT Windtree Therapeutics Inc
SVP & CFO1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 26, 2022 (view filing)4:38 PM ET | Jul 26 | Same day | Hamill John P.SVP & CFO | PPurchase | +3.00K | $0.3666 | +$1.10K | +4.3%72.8K after |